https://ift.tt/2IVHF6y

The stock slipped 7% to Rs 2,425 on the BSE after the pharmaceutical company said US health regulator issued eight observations after inspecting its formulations plant at Duvvada, Visakhapatnam.

from Markets https://ift.tt/2P0rckJ

Comments

Popular posts from this blog

MPL accuses ASCI of 'tampering' with ads